|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-5-7
|
|
pubmed:abstractText |
The renin-angiotensin system plays an important role in hepatic fibrogenesis and in portal hypertension. To examine the long-term effects of Candesartan cilexetil, an angiotensin type 1 (AT1) receptor blocker, on portal-systemic haemodynamics and on liver fibrosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Hyaluronic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Procollagen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1,
http://linkedlifedata.com/resource/pubmed/chemical/candesartan cilexetil
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:AlessandriaCarloC,
pubmed-author:BiasiFiorellaF,
pubmed-author:BonardiRenatoR,
pubmed-author:BrunelloFrancoF,
pubmed-author:Debernardi-VenonWilmaW,
pubmed-author:MartiniSilviaS,
pubmed-author:MarzanoAlfredoA,
pubmed-author:PoliGiuseppeG,
pubmed-author:RizzettoMarioM,
pubmed-author:SaraccoGiorgioG,
pubmed-author:TermineAngelaA,
pubmed-author:VizioBarbaraB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1026-33
|
|
pubmed:dateRevised |
2007-12-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17336417-Adult,
pubmed-meshheading:17336417-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:17336417-Benzimidazoles,
pubmed-meshheading:17336417-Biphenyl Compounds,
pubmed-meshheading:17336417-Female,
pubmed-meshheading:17336417-Fibrosis,
pubmed-meshheading:17336417-Humans,
pubmed-meshheading:17336417-Hyaluronic Acid,
pubmed-meshheading:17336417-Liver,
pubmed-meshheading:17336417-Male,
pubmed-meshheading:17336417-Middle Aged,
pubmed-meshheading:17336417-Portal Pressure,
pubmed-meshheading:17336417-Procollagen,
pubmed-meshheading:17336417-Receptor, Angiotensin, Type 1,
pubmed-meshheading:17336417-Renin-Angiotensin System,
pubmed-meshheading:17336417-Tetrazoles,
pubmed-meshheading:17336417-Transforming Growth Factor beta1
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers.
|
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, S Giovanni Battista Hospital, Turin, Italy. wilmadebernardi@yahoo.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
